Applicant, as named in the Orange Book
Novartis Pharm
Next listed expiry: Tabrecta on 22 Jul 2035. 1 products with live protection, 1 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Tabrecta · 2 strengths capmatinib hydrochloride | 22 Jul 2035 |
Recent events
- 25 Oct 2026Afinitor Disperz · Generic approved 9 Jan 2026
- 25 Oct 2026Afinitor Disperz · Generic approved 21 Sep 2026
Products without listed protection (1)
| Drug | Earliest generic entry |
|---|---|
| Afinitor Disperz · 3 strengths everolimus | open now |